Zalicus Pharmaceuticals, Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zalicus Pharmaceuticals, Ltd..The latest application filed is for "n-piperidinyl acetamide derivatives as calcium channel blockers".

Company Profile

0.9.15

Zalicus Pharmaceuticals, Ltd. - Boston MA US
ZALICUS PHARMACEUTICALS, LTD. - Cambridge MA US
Zalicus Pharmaceuticals Ltd. - Vancouver CA
Zalicus Pharmaceuticals Ltd. - Cambrisge MA
Zalicus Pharmaceuticals Ltd. -
Zalicus Pharmaceuticals Ltd. - Vancover BC
Zalicus Pharmaceuticals Ltd. - Vancojuver, British Columbia CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20160175315 - PAJOUHESH; Hassan ; et al.	2016-06-23
Heterocyclic Inhibitors Of The Sodium Channel App 20160016939 - PAJOUHESH; Hassan ; et al.	2016-01-21
Benzimidazole Inhibitors Of The Sodium Channel App 20150361032 - PAJOUHESH; Hassan ; et al.	2015-12-17
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 9,096,522 - Pajouhesh , et al. August 4, 2	2015-08-04
Benzimidazole Inhibitors Of The Sodium Channel App 20140187533 - Pajouhesh; Hassan ; et al.	2014-07-03
Bisarylsulfone And Dialkylarylsulfone Compounds As Calcium Channel Blockers App 20140113898 - Pajouhesh; Hassan A. ; et al.	2014-04-24
Oxopiperazine derivatives for the treatment of pain and epilepsy Grant 8,629,149 - Pajouhesh , et al. January 14, 2	2014-01-14
N-piperidinyl Acetamide Derivatives As Calcium Channel Blockers App 20140011996 - Pajouhesh; Hassan ; et al.	2014-01-09
Solid dispersion formulations and methods of use thereof Grant 8,591,944 - Padval , et al. November 26, 2	2013-11-26
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 8,569,344 - Pajouhesh , et al. October 29, 2	2013-10-29
Solid Dispersion Formulations And Methods Of Use Thereof App 20130231350 - Padval; Mahesh V. ; et al.	2013-09-05
Self-emulsifying Formulations And Methods Of Use Thereof App 20130184290 - PADVAL; Mahesh V. ; et al.	2013-07-18
Solid dispersion formulations and methods of use thereof Grant 8,409,560 - Padval , et al. April 2, 2	2013-04-02
N-piperidinyl acetamide derivatives as calcium channel blockers Grant 8,377,968 - Pajouhesh , et al. February 19, 2	2013-02-19
Solid Dispersion Formulations And Methods Of Use Thereof App 20130035345 - Padval; Mahesh V. ; et al.	2013-02-07
Method for increasing the bioavailability of benzhydryl piperazine containing compounds Grant 8,362,021 - Snutch , et al. January 29, 2	2013-01-29
Solid Dispersion Formulations And Methods Of Use Thereof App 20120252819 - Padval; Mahesh V. ; et al.	2012-10-04
Aryl Sulphone Derivatives As Calcium Channel Blockers App 20120245137 - Pajouhesh; Hassan A. ; et al.	2012-09-27
Selective Calcium Channel Modulators App 20120220564 - Pajouhesh; Hassan ; et al.	2012-08-30
Substituted Heterocyclic Derivatives For The Treatment Of Pain And Epilepsy App 20120220603 - Pajouhesh; Hassan ; et al.	2012-08-30
Oxopiperazine Derivatives For The Treatment Of Pain And Epilepsy App 20120220605 - Pajouhesh; Hassan ; et al.	2012-08-30
Bicyclic pyrimidine derivatives as calcium channel blockers Grant 8,133,998 - Pajouhesh , et al. March 13, 2	2012-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.